12th Feb 2013 07:00
Standard Form TR-1Voting rights attached to shares- Article 12(1) of directive 2004/109/ECFinancial instruments - Article 11(3) of the Commission Directive 2007/14/EC
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: UNITED DRUG PUBLIC LIMITED COMPANY
2. Reason for the notification (please tick the appropriate box or boxes):
[ X] an acquisition or disposal of voting rights
[ ] an acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached
[ ] an event changing the breakdown of voting rights
3. Full name of person(s) subject to the notification obligation:
AVIVA PLC AND ITS SUBSIDIARIES
4. Full name of shareholder(s) (if different from 3.):
REGISTERED HOLDER:
BNY Norwich Union Nominees Limited 803,795*
Chase (GA Group) Nominees Ltd 6,602,811*
Chase Nominees Limited 562,955*
CUIM Nominee Limited 249,004*
Vidacos Nominees Limited 9,900*
*denotes direct interest
Chase (GA Group) Nominees Ltd 121,000
Chase Nominees Limited 898,980
Vidacos Nominees Limited 81,000
BNP Paribas - London 95,908
5. Date of the transaction and date on which the threshold is crossed or reached:
08 FEBRUARY 2013
6. Date on which issuer notified;
11 FEBRUARY 2013
7. Threshold(s) that is/are crossed or reached:
4% TO 3% CHANGE AT COMBINED DIRECT AND INDIRECT INTEREST LEVEL
8. Notified details:
1.
1. 1. 1.
A) Voting rights attached to shares | |||||||
Class/type of shares (if possible using the ISIN CODE) | Situation previous to the Triggering transaction | Resulting situation after the triggering transaction | |||||
| Number of Shares | Number of Voting rights | Number of shares | Number of voting rights | % of voting rights | |||
| Direct | Direct | Indirect | Direct | Indirect | |||
IE0033024807 | 8,085,379 | 8,085,379 | 9,425,353 | 8,228,465 | 1,196,888 | 3.43% | 0.50 |
B) Financial Instruments | ||||
Resulting situation after the triggering transaction | ||||
Type of financial instrument | Expiration Date | Exercise/Conversion Period/ Date | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
SUBTOTAL B (in relation to all expiration dates) | ||||
Total (A+B) | number of voting rights | % of voting rights |
9,425,353 | 239,808,133 | 3.93% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable:
The voting rights are managed and controlled by Aviva Investors Global Services Limited, with the following chain of controlled undertakings:-
Aviva Investors Global Services Limited:
·; Aviva plc (Parent Company)
·; Aviva Group Holdings Limited (wholly owned subsidiary of Aviva plc)
·; Aviva Investors Holdings Limited (wholly owned subsidiary of Aviva Group Holdings Limited)
·; Aviva Investors Global Services Limited (wholly owned subsidiary of Aviva Investors Holdings Limited)
10. In case of proxy voting:[name of the proxy holder] will cease to hold [number] voting rights as of [date].
11. Additional information:
Figures are based on a total number of voting rights of 239,808,133 as per the Company's Total Voting Rights Announcement of 1 February 2013.
Annex to the standard form TR-1
a) Identity of the person or legal entity subject to the notification obligation:
Full name (including legal form for legal entities) | UNITED DRUG PUBLIC LIMITED COMPANY................................ |
Contact address (registered office for legal entities) | UNITED DRUG HOUSE MAGNA DRIVE MAGNA BUSINESS PARK CITYWEST ROAD DUBLIN 24 REPUBLIC OF IRELAND............ ..................................................................... |
Phone number | .................................................................... |
Other useful information (at least legal representative for legal persons) | ……………………………………………. |
b) Identity of the notifier, if applicable:
Full name | NEIL WHITTAKER GLOBAL REPORTING UNIT AVIVA PLC SURREY STREET NORWICH NR1 3DR UNITED KINGDOM.................. |
Contact address | ..................................................................... ..................................................................... |
Phone number | 00 44 1603 684420 .................................................................... |
Other useful information (e.g. functional relationship with the person or legal entity subject to the notification obligation) |
|
c) Additional information
Related Shares:
AvivaUDG.L